墨西哥含糖饮料税收政策对糖尿病和心血管疾病影响的模型研究
研究使用墨西哥心血管疾病政策模型,模拟10年内含糖饮料消费量减少10%和20%对糖尿病发病、心血管事件、医疗费用和死亡率的影响。
核心结论
- 基于观察到的消费减少,墨西哥含糖饮料税可能大幅降低糖尿病和心血管疾病的发病率和死亡率,同时减少医疗费用。
研究设计与样本
- 使用墨西哥心血管疾病政策模型,一种针对35-94岁墨西哥成年人的状态转换模型,预测10年内含糖饮料摄入减少对糖尿病发病率、心血管事件、直接糖尿病医疗费用和死亡率的影响。
- 模型输入包括税收后含糖饮料消费的短期变化(价格弹性)、政府和市场调查数据以及公共医疗机构数据。
- 模拟两种主要情景:含糖饮料消费减少10%(对应税收实施后观察到的减少)和减少20%(可能通过提高税率和/或额外措施实现)。
- 评估了一系列热量补偿值以反映不确定性。
主要发现
- 在含糖饮料消费减少10%且39%热量补偿情景下,预计2013至2022年减少约189300例(95%不确定性区间155400-218100)新发2型糖尿病。
- 同情景下预计减少20400例卒中和心肌梗死,减少18900例死亡。
- 该情景预测可为墨西哥节省983百万国际元(95%不确定性区间769百万-1173百万国际元)。
- 糖尿病和心血管事件的相对与绝对减少在建模的最年轻年龄组(35-44岁)最大。
关键数值与推荐
- 含糖饮料消费减少10%且39%热量补偿:减少约189300例2型糖尿病(95%UI 155400-218100)。
- 同情景:减少20400例卒中和心肌梗死,减少18900例死亡。
- 同情景:节省983百万国际元(95%UI 769百万-1173百万国际元)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 研究依赖美国研究数据作为某些输入,因缺乏墨西哥特定数据,具体为风险因素与心血管疾病结局之间的关联(来自弗雷明汉心脏研究)和含糖饮料热量补偿假设。
- 除糖尿病相关费用外,医疗费用数据有限。
- 缺乏针对地理和经济亚组的长期含糖饮料价格弹性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Rates of diabetes in Mexico are among the highest worldwide. In 2014, Mexico instituted a nationwide tax on sugar-sweetened beverages (SSBs) in order to reduce the high level of SSB consumption, a preventable cause of diabetes and cardiovascular disease (CVD). We used an established computer simulation model of CVD and country-specific data on demographics, epidemiology, SSB consumption, and short-term changes in consumption following the SSB tax in order to project potential long-range health and economic impacts of SSB taxation in Mexico. METHODS AND FINDINGS: We used the Cardiovascular Disease Policy Model-Mexico, a state transition model of Mexican adults aged 35-94 y, to project the potential future effects of reduced SSB intake on diabetes incidence, CVD events, direct diabetes healthcare costs, and mortality over 10 y. Model inputs included short-term changes in SSB consumption in response to taxation (price elasticity) and data from government and market research surveys and public healthcare institutions. Two main scenarios were modeled: a 10% reduction in SSB consumption (corresponding to the reduction observed after tax implementation) and a 20% reduction in SSB consumption (possible with increases in taxation levels and/or additional measures to curb consumption). Given uncertainty about the degree to which Mexicans will replace calories from SSBs with calories from other sources, we evaluated a range of values for calorie compensation. We projected that a 10% reduction in SSB consumption with 39% calorie compensation among Mexican adults would result in about 189,300 (95% uncertainty interval [UI] 155,400-218,100) fewer incident type 2 diabetes cases, 20,400 fewer incident strokes and myocardial infarctions, and 18,900 fewer deaths occurring from 2013 to 2022. This scenario predicts that the SSB tax could save Mexico 983 million international dollars (95% UI $769 million-$1,173 million). The largest relative and absolute reductions in diabetes and CVD events occurred in the youngest age group modeled (35-44 y). This study's strengths include the use of an established mathematical model of CVD and use of contemporary Mexican vital statistics, data from health surveys, healthcare costs, and SSB price elasticity estimates as well as probabilistic and deterministic sensitivity analyses to account for uncertainty. The limitations of the study include reliance on US-based studies for certain inputs where Mexico-specific data were lacking (specifically the associations between risk factors and CVD outcomes [from the Framingham Heart Study] and SSB calorie compensation assumptions), limited data on healthcare costs other than those related to diabetes, and lack of information on long-term SSB price elasticity that is specific to geographic and economic subgroups. CONCLUSIONS: Mexico's high diabetes prevalence represents a public health crisis. While the long-term impact of Mexico's SSB tax is not yet known, these projections, based on observed consumption reductions, suggest that Mexico's SSB tax may substantially decrease morbidity and mortality from diabetes and CVD while reducing healthcare costs.
引用
- Sánchez-Romero LM, Penko J, Coxson PG, et al. Projected Impact of Mexico's Sugar-Sweetened Beverage Tax Policy on Diabetes and Cardiovascular Disease: A Modeling Study. PLoS Med. 2016. PMID: 27802278. doi:10.1371/journal.pmed.1002158
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。